Clinical Trials Directory

Trials / Completed

CompletedNCT06044818

Validation of Accexible as a Tool for Screening and Monitoring Depression.

Validación Del Sistema de Cribaje y Seguimiento de acceXible Para depresión.

Status
Completed
Phase
Study type
Observational
Enrollment
166 (actual)
Sponsor
Accexible · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Major depressive disorder (MDD) is a chronic disease with a prevalence around 8-12% and is considered one of the most debilitating disease worldwide. A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness. The present study has the objective of validating Accexible as a tool for Screening and Monitoring Depression.

Conditions

Interventions

TypeNameDescription
DEVICEAccexibleSpeech Analysis

Timeline

Start date
2023-07-10
Primary completion
2025-04-17
Completion
2025-04-17
First posted
2023-09-21
Last updated
2026-03-25

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06044818. Inclusion in this directory is not an endorsement.